Neutrophil depletion fails to modify myocardial no reflow and functional recovery after coronary reperfusion  by Carlson, Robert E. et al.
JACC Vol. 14, No. 7 
December 1989: 180343 
1803 
Neutrophil Depletion Fails to Modify Myocardial No Reflow and 
Functional Recovery After Coronary Reperfusion 
ROBERT E. CARLSON, BS, ROBERT J. SCHOTT, MD. ANDREW J. BUDA, MD, FACC 
Ann Arbor, Michigan 
Recent studies suggest that neutrophil accumulation and 
activation in postischemic myocardium may be responsible 
for myocardial no reflow, which is characterized by an 
incomplete restoration of blood flow after reperfusion. To 
examine this further, 11 open chest, anesthetized dogs 
received bolus injections of a bovine neutrophil antiserum 
that produced an average 81 + 5% depletion of circulating 
neutrophils, and 10 control dogs received nonimmune 
serum. Each animal underwent 2 h of left circumflex artery 
occlusion followed by 4 h of reperfusion. Simultaneous 
two-dimensional echocardiography and radioactive micro- 
sphere blood flow studies were performed at baseline, 2 h of 
occlusion and early (-5 min) and 4 h of reperfusion. 
During occlusion, both groups developed similar reduc- 
tions in myocardial blood flow and levels of ischemic zone 
myocardial wall thinning. At early reperfusion, similar 
levels of byperemia and regional hypokinesia were observed 
for both groups. By late reperfusion, both groups experi- 
enced significant no reflow in the subendocardium (p < 
0.05) and reduced reflow in the mid-myocardium. Regional 
depression in ischemic zone function persisted throughout 
the reperfusion period in both groups. However, infarct 
size expressed as a percent of left ventricular weight, 
assessed by triphenyltetrazolium chloride staining, was 
smaller for the neutrophil depletion group compared with 
the control group (8.7 f 1.3% versus 13.1 + 1.8%, p < 
0.05). 
It is concluded that an 81% neutrophil depletion fails to 
modify the no reflow phenomenon or improve functional 
recovery after 2 h of coronary artery occlusion and 4 h of 
coronary reperfusion despite modification of the ultimate 
size of necrosis. 
(J Am Co11 Cardiol1989;14:1803-13) 
Neutrophil accumulation and activation are believed to 
contribute to the progression of acute myocardial infarction, 
myocardial no reflow and the progressive impairment of 
functional recovery that develops after acute myocardial 
ischemia and reperfusion. Neutrophil depletion (l-4,6) and 
other maneuvers (5-g) that affect neutrophil action have 
resulted in a significant reduction in experimental myocar- 
dial injury in various ischemia-reperfusion models. Although 
it is apparent that neutrophils contribute to the acute patho- 
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genesis of postischemic myocardium, the exact mechanisms 
involved are unclear. Recent studies (9-11) have shown that 
neutrophils accumulate during ischemia in proportion to the 
severity of the ischemic insult (9) and also accumulate during 
reperfusion (9-l 1). The mechanisms of neutrophil-mediated 
tissue injury may be related to any one or possible combi- 
nation of the following: 1) plugging of the microvasculature, 
which may impede myocardial blood flow in the reperfusion 
phase (9,12-14); 2) activation and production of toxic metab- 
elites, producing lipid peroxidation and myocardial tissue 
damage (15-17); and 3) and increase in vascular permeability 
that leads to interstitial edema and elevated extravascular 
resistance to blood flow (2,9,14). 
Studies using light microscopy (12) and radioactive neu- 
trophil-labeling techniques (9,lO) suggest that neutrophil 
plugging may be a primary source of ischemic and postis- 
chemic myocardial no reflow and related tissue injury. 
However, no study to date has specifically examined 
whether the cardioprotective maneuver of neutrophil deple- 
tion actually alters myocardial blood flow characteristics in a 
no reflow model of ischemia and reperfusion. Accordingly, 
we designed an experiment to study the effects of neutrope- 
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nia on myocardial blood flow and wall thickening character- 
istics during both early and late periods of reperfusion after 
a 2 h coronary artery occlusion. 
Methods 
Experimental procedures complied with the “Guiding 
Principles in the Use and Care of Animals” approved by the 
Council of the American Physiological Society as well as 
with state and federal laws. 
Neutrophil depletion. Canine neutrophils were isolated 
from whole blood by centrifugation over a two density Ficoll 
hypaque gradient (Histopaque 1077and 1119, Sigma Chemi- 
cals) modified from the technique described by English and 
Abrahams (18). The neutrophils were separated with red 
cells that were subsequently lysed with a buffered ammo- 
nium chloride solution and washed twice with Hank’s solu- 
tion (without calcium and magnesium). Neutrophil purity of 
nearly 100% was verified by Wright’s stain and microscopy. 
Three milliliters of purified neutrophils containing approxi- 
mately 1 x lo8 neutrophils was mixed with an equal volume 
of Freund’s complete adjuvant and inoculated into 20 intra- 
and subdermal sites along the back of a sheep. Ten days 
later, the same sheep was reinoculated with a second aliquot 
of neutrophils similarly prepared, but mixed with an equal 
volume of Freund’s incomplete adjuvant. The sheep blood 
was harvested 15 days later and allowed to clot overnight. 
The remaining serum was frozen (-20°C) until use. Nonim- 
mune serum was obtained from uninoculated sheep. 
Previous testing of the immune serum in healthy mongrel 
dogs indicated that a 3 ml intravenous injection produced 
profound neutropenia with 15 min, but platelet counts and 
red blood cell counts measured on an automated counter 
(model S Plus Coulter Counter) remained within the normal 
range. There was a tendency for neutrophil counts to in- 
crease beginning about 90 min after the injection of immune 
serum, associated with a shift from mature segmented neu- 
trophils to immature band forms over time. 
Instrumentation. A total of 21 anesthetized, open chest, 
male mongrel dogs (22 to 31 kg) were studied. Each dog was 
anesthetized intravenously with thiamylal (20 mglkg) fol- 
lowed by pentobarbital(30 mglkg) as needed, and underwent 
a left thoracotomy in the fifth intercostal space. Catheters 
were placed in the left internal jugular vein for fluid and drug 
administration, the left femoral artery for measurement of 
arterial blood pressure, the left carotid and right femoral 
arteries for the withdrawal of reference arterial blood sam- 
ples and the left atria1 appendage for the administration of 
radioactive-labeled microspheres. For the determination of 
myocardial blood flow approximately 1 to 2 X lo6 carbon- 
ized plastic microspheres (15 pm diameter) were infused 
labeled with one of the following isotopes: scandium -46, 
rubidium -103, cerium - 141, niobium -95, chromium -51 
and selenium - 113. A proximal portion of the left circumflex 
coronary artery was isolated, and an electomagnetic flow 
probe was placed around the vessel for verification of 
coronary occlusion and identification of peak hyperemia 
during reperfusion. A snare-type occluder was placed just 
distal to the probe. 
Experimental protocol. During instrumentation, the ani- 
mals were randomly assigned to receive a baseline 3 ml 
intravenous bolus of either the immune (n = 11) or nonim- 
mune (n = 10) serum. Administration of the serum was 
repeated at 30 min and 2 h of coronary occlusion and at 30 
min and 1.5, 2.5 and 3.5 h of reperfusion. Arterial blood 
samples were obtained to determine white blood cell counts 
before and after the baseline bolus, at 1.5 h of coronary 
occlusion and at 5 min and 2 and 4 h of reperfusion. All white 
blood cell counts were performed with a hemocytometer 
after red cell lysis (Unopett, Beckman-Dickinson). Differen- 
tial white cell counts were made on monolayered smears 
using Wright-Giemsa (Ames Hema-Trek II) stain. Immune 
serum administration reduced the neutrophil count by 87 + 
4% from baseline. The level of circulating neutrophils grad- 
ually increased throughout the protocol and resulted in an 
average depletion level of 81 ? 5%. 
During baseline conditions, a short-axis two-dimensional 
echocardiogram was acquired in each dog at the mid- 
papillary muscle level. Concurrently, hemodynamic mea- 
surements were obtained and a microsphere administration 
was performed. The left circumflex coronary artery was then 
occluded for 2 h. Just before releasing the occlusion, a 
second microsphere infusion, echocardiogram and hemody- 
namic measurements were obtained. In both groups, each 
dog received a 50 mg bolus of lidocaine just before reperfu- 
sion. Immediately after reperfusion (-5 min) and corre- 
sponding with the achievement of peak hyperemia as indi- 
cated by flow probe tracings, a third microsphere infusion, 
echocardiogram and hemodynamic measurements were per- 
formed. Just before 4 h of reperfusion, a fourth set of 
regional blood flow, function and hemodynamic measure- 
ments were made. 
Infarct size determination. At 4 h of reperfusion, the 
animal was killed with an intravenous bolus injection of a 
saturated potassium chloride solution, and the heart was 
excised. The left ventricle was isolated and frozen for later 
sectioning into 5 mm thick short-axis slices. Each slice was 
weighed and placed in a 4% triphenyltetrazolium chloride 
solution buffered with a 0.1% dipotassium phosphate solu- 
tion for 10 min to determine the area of myocardial necrosis 
for each slice. Tracings of left ventricular slices were made 
on acetate sheets. Areas of necrosis for each slice of the left 
ventricle were identified to calculate infarct size as a percent 
of the area of each slice using standard planimetric tech- 
niques. The slices were then placed in a 10% formaldehyde 
solution until sectioning was performed to determine blood 
flows with the microsphere technique (19). 
The area of each slice and any infarcted tissue were 
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Figure 1. A schematic illustration of the general 
instrumentation and the focal plane of regional 
myocardial blood flow and two-dimensional 
echocardiographic functional analysis. An elec- 
tromagnetic flow probe was placed on a proximal 
portion of the left circumflex coronary artery, 
and a snare-type occluder was positioned dis- 
tally. A left atria1 catheter was inserted to moni- 
tor left atria1 pressure and serve as the radioac- 
tive microsphere injection port for radioactive 
blood flow analysis. Two short-axis slices of the 
left ventricle at the mid-papillary muscle level 
were divided into central ischemic and non- 
ischemic zone segments. Subepicardial, mid- 
myocardial and subendocardial pieces of each 
transmural section were analyzed for radioactive 
microsphere content. The two-dimensional 
echocardiograms were analyzed using similar 
short-axis radial divisions to determine the cor- 
responding central ischemic and nonischemic 
zone wall thickening values. 
Snare Occluder 
and Yyocardial Blood Flow 
Measurements 
determined by planimetry using a Microsonics IBM AT 
microcomputer. The percent of the infarcted left ventricle 
was calculated by adding up the areas of the infarcted tissue 
in each slice and dividing this value by the total area of all the 
slices. The percent of infarcted tissue was multiplied by the 
left ventricular weight to determine the relative weight of the 
infarction. Infarct size was calculated as ([infarct weight/left 
ventricular weight] x 100%) to yield the relative percent of 
the left ventricular weight that was infarcted. 
Regional myocardial blood flow determination. The distri- 
bution of regional coronary blood flow was determined by 
the reference withdrawal technique using methods previ- 
ously described (19). Two adjacent transverse left ventricu- 
lar slices (5 mm each) at the mid-papillary muscle level, 
corresponding to the echocardiographic short-axis imaging 
plane were selected (Fig. 1). Central ischemic and nonis- 
chemic zone divisions were determined by using a circum- 
ferential coordinate system that divided each short-axis slice 
into 16 full thickness 22.5” sectors, with the posterior papil- 
lary muscle fixed at 135”, corresponding to the central 
ischemic zone. Nonischemic zone segments were located 
approximately 180” from the central ischemic region on the 
coordinate plane. The appropriate sectors were subdivided 
into subendocardial, mid-myocardial and subepicardial sam- 
ples. Each was then weighed, placed into counting vials and 
assayed for radioactivity in a Tracer (model 1185) gamma 
scintillation counter. After correcting for background and 
overlap error, absolute myocardial blood flow was calcu- 
lated with the following equation: Qm = (Cm x QriCr), 
where Qm = myocardial blood flow (mlimin); Cm = counts/ 
min in the tissue sample; Qr = withdrawal rate of the 
reference arterial sample (ml/min) and Cr = counts/min in 
the reference arterial sample. Myocardial blood flow was 
expressed per gram of tissue for each sample. 
Echocardiographic analysis. Regional myocardial wall 
thickening was determined for the short-axis echocardio- 
graphic sequences using a Microsonics IBM AT-based video 
digitizing system. An experienced observer selected end- 
diastolic and end-systolic frames using the onset of the Q 
wave in electrocardiographic lead II to define end-diastole 
and the smallest ventricular cavity to define end-systole. 
Endocardial and epicardial borders were traced directly on 
the video display for three successive heartbeats using a 
digitizing tablet. Computer-assisted analysis of regional wall 
thickening was made using a radial contraction model with a 
fixed diastolic center of mass at 22.5” intervals over the full 
left ventricular circumference. For correction of rotation, 
the mid-point of the posterior papillary muscle was fixed at 
135”. Wall thickening was calculated as: ([end-systolic wall 
thickness - end-diastolic wall thicknessllend-diastolic wall 
thickness) x 100%. 
The normal range ofwall thickening was determined from 
a functional map of the baseline images for three cardiac 
cycles, and 95% confidence limits were established in each 
animal. These limits were used for comparison with occlu- 
Table 1. Neutrophil Data (PMNsimm’) 
Depletion 
(n = it) 
Control 
(n = 7) 
Baseline 
Baseline (after serum) 
2 h occlusion 
5 min repetfusion 
4 h reperfusion 
7,132 t 1,182 9.933 f 1,511 
659 ? 129*: 5,287 _t I,3299 
127 + 9o*t 9,328 ? 3,272 
844 ? 237*f 11,097 ? 3.071 
2,028 ? 545** 17.264 2 3,037t 
*p < 0.01 vs. control; tp < 0.05 vs. baseline: Sp < 0.01 vs. baseline. 
Values are reported as mean values + SEM. PMNs = polymorphonuclear 
neutrophils. 
1806 CARLSON ET AL. 
NEUTROPHIL DEPLETION AND MYOCARDIAL NO REFLOW 
JACC Vol. 14, No. 7 
December 1989:1803-13 
Figure 2. Absolute neutrophil counts compared be- 
tween the neutrophil depletion (Depletion) and control 
(Control) groups throughout the protocol. Note the 
significant levels of neutrophil depletion between the 
two groups (p < 0.01). **p < 0.01 versus control. 
Be&line Ba&ns 2-h 5 An 4-h 
post serum Occlusion Reperfusion Reperfuslon 
sion and reperfusion functional maps, and abnormalities 
were expressed as the circumferential extent and degree of 
dysfunction. The extent of dysfunction was defined as the 
number of degrees between curve intercepts for the dysfunc- 
tional portion of the occlusion and reperfusion function maps 
and the lower tolerance limit; the degree of dysfunction was 
measured as the planimetered area of the map, as deter- 
mined by planimetry contained within the dysfunctional 
area. 
Exclusion criteria. A total of 48 dogs were studied. There 
were 21 successful experiments from which 10 vehicle 
control dogs and 11 neutrophil-depleted dogs resulted. Of 
the remaining 27 dogs, 5 were studied to verify and deter- 
mine the effective dosage of the immune serum to be 
administered to obtain maximal neutrophil depletion for the 
study. Eleven dogs developed ventricular fibrillation during 
occlusion and 5 fibrillated during reperfusion. No effort was 
made to resuscitate the animal after ventricular fibrillation, 
and the information was excluded from the final analysis. 
There was no significant difference for the incidence of 
fibrillation between the two groups. Four dogs were ex- 
cluded on the basis of the presence of high collateral blood 
flow (>0.2 mllmin per g, n = 3) or the absence of dysfunction 
assessed using two-dimensional echocardiography during 
occlusion (n = 1), or both (20). In addition, one dog 
developed an allergic reaction to the serum and one had no 
evidence of reperfusion after subsequent analysis of the 
myocardial blood flow and functional data. 
Statistical analysis. All data are expressed as mean values 
-+ SEM. Appropriate statistical analysis of values was made 
by use of a two-tailed, unpaired Student’s t test for deter- 
mining intergroup differences. One way analysis of variance 
was used to examine intragroup differences, employing 
Bonferroni’s correction to determine significant differences 
from baseline values. The probability (p) was considered to 
be statistically significant when p < 0.05. 
Results 
Neutrophil depletion data (Table 1, Fig. 2). Administra- 
tion of the immune serum initially reduced the number of 
circulating neutrophils by 87 ? 4% compared with preserum 
levels in the neutrophil depletion group (n = 11). The level of 
neutrophil depletion rebounded slightly by 4 h of reperfusion 
to 68 k 8%. Total neutrophil depletion averaged 81 k 5% 
over the course of the experiment. The average neutrophil 
count in the control group (n = 7) increased 76% compared 
with baseline. The control group developed a temporary 
reaction to the nonimmune serum at the baseline period, 
resulting in a minor level of neutrophil depletion. However, 
by 2 h of occlusion, the levels of circulating neutrophils were 
similar to baseline levels, and by 4 h of reperfusion, in- 
creased significantly above baseline counts. 
Infarct size data (Fig. 3). Infarct size expressed as a 
percent of left ventricular weight was significantly lower 
(p < 0.05) for the depletion group (8.7 -+ 1.3%, n = 11) than 
for the control group (13.1 2 1.8%, n = 10). 
Figure 3. Myocardial infarct (INF) size expressed as a percent of 
left ventricular (LV) mass. Individual points are depicted with the 
mean rt_ standard error of the mean (SEM) for the depletion and 
control groups. Squares = mean 5 SEM. *p < 0.05 versus control. 
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Table 2. Hemodynamic Data 
HR (beatslmin) 
Depletion Control 
(n = II) (n = IO) 
MAP (mm Hg) 
Depletion Control 
(n = II) (n = 10) 
LAP (mm Hg) 
Depletion Control 
(n = 11) (n = 10) 
Baseline 138 ? 6 140 + 5 115 t 8 121 + 6 4.2 rt 0.7 3.7 lr 0.9 
2 h occlusion 127 + 8 138 t 6 123 + 10 124 t- Y 6.3 + 1.1: 5.9 t 1.2f 
5 min reperfusion 126 + 7 141 + 7 117 + 8 117 -+ 8 7.5 ? 1.1* 6.8 ? 1.1: 
4 h reperfusion 129 ? lO* 155 +6 105 2 9 116 t 7 8.0 2 1.9 7.5 i- I.?t 
*p < 0.05 vs. control: tp < 0.05 vs. baseline; $p < 0.01 vs. baseline. Data are reported as mean values f SEM. HR = heart rate: LAP = left atrial pressure: 
MAP = mean arterial pressure. 
Hemodynamic data (Table 2). No statistically significant There was no difference in the functional severity of the 
differences in heart rate or mean arterial pressure were noted ischemic insult between the two groups (Table 4). The extent 
between the depletion and control groups or relative to their and degree of dysfunction were not significantly different. 
individual baseline values. In both groups, significant in- Five minutes of reperfusion produced a significant decrease 
creases in left atria1 pressure were evident at 2 h of occlusion in both the extent and degree of dysfunction measures for 
and early reperfusion. After 4 h of reperfusion, both groups the depletion (p < 0.01) and control (p < 0.01) groups 
retained an elevated left atria1 pressure compared with compared with occlusion values. After 4 h of reperfusion, 
baseline, although it was only statistically significant for the however, the extent and degree of dysfunction increased to 
control group. In addition, the depletion group had a signif- values approaching those observed during occlusion in both 
icantly lower heart rate by 4 h of reperfusion compared with groups. Notably, the depletion group was characterized by 
the control group; however, there was no significant differ- significantly less dysfunction compared with its occlusion 
ence of rate-pressure product between the groups. level in contrast to the control group. 
Ecbocardiographic data (Tables 3 and 4). Both the deple- 
tion and control groups were characterized by significant 
increases in left ventricular end-systolic area and end- 
diastolic area after 2 h of occlusion (Table 3). A relative 
return of left ventricular end-systolic area and left ventricu- 
lar end-diastolic area near baseline values occurred at early 
reperfusion for both groups. By 4 h of reperfusion, the 
control group developed moderate but significant increases 
in left ventricular end-systolic area and left ventricular 
end-diastolic area compared with baseline values. In both 
groups, area ejection fraction during occlusion decreased 
significantly from baseline values. After reperfusion the 
depletion and control groups experienced relative increases 
in area ejection fraction (25.9 ? 1.5 and 25.0 ? 1.6%, p = NS 
versus baseline). After 4 h of reperfusion, the area ejection 
fraction was decreased relative to baseline values in the 
depletion (22.3 t- 2.2 versus 30.2 2 2.7%, p = NS) and 
control (20.6 -t 2.0 versus 28.2 f 2.3%, p < 0.01) groups. 
Regional myocardial function (Table 5, Fig. 4). By 2 h of 
occlusion, wall thickening in the central ischemic zone 
decreased significantly compared with baseline values in 
both the depletion (-3.0 + 0.9 versus 31.4 t 0.9%, p < 0.01) 
and control (-1.7 ? 1.0 versus 30.0 + 1.2%, p < 0.01) 
groups. Concurrently, increases from baseline values in 
nonischemic zone function were noted in the depletion 
(45.1 2 2.8 versus 35.5 ‘_ 2.7%, p = NS) and control (45.8 t- 
3.5 versus 32.1 2 1.9%, p < 0.05). At early reperfusion, 
central ischemic zone wall thickening in both groups showed 
a slight improvement to a hypokinetic state, but deteriorated 
progressively throughout the reperfusion period. By 4 h after 
reperfusion, central ischemic zone wall thickening was aki- 
netic. In both groups, early and late reperfusion central 
ischemic zone function remained significantly depressed 
compared with baseline values. Nonischemic zone function 
declined toward baseline values throughout reperfusion in 
both groups. Neutrophil depletion was not associated with 
Table 3. Echocardiographic Data 
Baseline 
2 h occlusion 
5 min reperfusion 
4 h reperfusion 
LVESA (cm’) 
Depletion Control 
(n = 9) (n = 9) 
13.6 t 1.1 13.7 + 1.1 
18.4 5 0.9t 17.7 + 0.9f 
15.6 2 0.9 15.0 ir 1.0 
16.1 k 1.1 17.9 ? 1.U 
LVEDA (cm’) 
Depletion Control 
(n = 9) (n = 9) 
19.3 ? 1.1 18.9 2 1.1 
22.9 ? 0.9* 22.9 ? l.Ot 
21.1 rt 1.0 19.9 t I.1 
20.7 + 1.2 22.4 ? 1.6+ 
AEF (%) 
Depletion Control 
(n = 9) (n = 9) 
30.2 t 2.7 28.2 + 2.3 
19.6 2 l.l* 21.2 + 1.5* 
25.9 ? 1.5 25.0 2 1.6 
22.3 + 2.2 20.6 2 2.0t 
*p < 0.05 vs. baseline; ip < 0.01 vs. baseline. Values are reported as mean values + SEM. AEF = area ejection fraction; LVEDA and LVESA = left 
ventricular end-diastolic and end-systolic area, respectively. 
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Table 4. Indexes of Dysfunction 
Degree (area) (mm’) Extent (“) 
Depletion Control Depletion Control 
(n = 9) (n = 9) (n = 9) (n = 9) 
2 h occlusion 3,460 t 285 2,891 + 244 183 ? 9 182 ? 13 
5 min reperfusion 1,681 t 442t 1,556 ? 338t 127 + 16* 135 2 13t 
4 h reperfusion 1,910 t 371* 2,400 2 369 168 t IO I65 ? 14 
*p < 0.05 vs. occlusion; tp < 0.01 vs. occlusion. Data are reported as 
mean values 2 SEM. 
better recovery in central ischemic zone function during 
reperfusion compared with the control group. 
Regional myocardial blood flow data (Table 6, Fig. 5 and 
6). The level of ischemia for the subendocardial, mid- 
myocardial and subepimyocardial tissue layers in the central 
ischemic zone was equivalent between the two groups and 
significantly lower compared with baseline values. Nonis- 
chemic zone blood flow at 2 h of occlusion for all three layers 
was not statistically different between the groups. Suben- 
docardial blood flow in the ischemic zone correlated with 
infarct size in both the depletion and control groups (y = 
-33.2x t 11.1, r = 0.57 and y = -124.5x t 18.2, r = 0.62, 
respectively). At 5 min of reperfusion, no differences in the 
levels of hyperemia were observed between the groups (Fig. 
4 and 5). The highest level of hyperemia was noted at the 
mid-myocardial tissue layer in both the depletion and control 
groups (3.73 ? 0.30 versus 3.94 ? 0.63 ml/min per g, p=NS), 
whereas a paradoxically lower response was noted in the 
subendocardium. The impaired hyperemia response in the 
subendocardium seen in both groups suggests that early 
myocardial no reflow was present in this layer. Significant no 
reflow in the subendocardium was evident by 4 h of reper- 
fusion in both groups (Fig. 5). A less severe depression in 
mid-myocardial blood flow by 4 h of reperfusion was appar- 
ent in the depletion group (p < 0.05) but not in the control 
group (p = NS). In addition, nonischemic zone mid- 
myocardial blood flow was significantly elevated in both 
groups by 4 h of reperfusion relative to baseline levels. 
Table 5. Wall Thickening Data 
Central Ischemic Zone Nonischemic Zone 
Depletion Control Depletion Control 
(n = 9) (n = 9) (n = 9) (n = 9) 
Baseline 31.4 + 0.9 30.0 4 1.2 35.5 2 2.7 32.1 + 1.9 
2 h occlusion -3.0 + 0.9t -1.7 + l.Ot 45.1 2 2.8 45.8 2 3.5* 
5 min reperfusion 8.4 k 3.6t 7.1 + 1.9t 42.9 + 3.6 42.6 ? 1.9* 
4 h reperfusion 5.3 + 1.7t 1.6 2 1.71 36.2 + 2.9 38.6 + 2.4 
*p < 0.05 vs. baseline; tp < 0.01 vs. baseline. Values are reported as 
mean values +- SEM. 
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Figure 4. Myocardial wall thickening at baseline, 2 h of occlusion, 
early reperfusion and 4 h of reperfusion. For each group, wall 
thickening in the nonischemic and ischemic zones is indicated. 
There were no significant differences between the depletion and 
control groups. 
Discussion 
In this ischemia-reperfusion model, a mean 81% depletion 
of neutrophils circulating with immune serum failed to alter 
myocardial blood flow patterns during reperfusion in com- 
parison with a nonimmune serum control group. However, 
this level of depletion reduced infarct size expressed as a 
percent of left ventricular weight, which is consistent with 
the results of previous studies (l-4,6). The reduction in 
ischemic damage coupled with a failure to alter myocardial 
reflow characteristics suggests that the primary source of 
neutrophil-mediated damage relates to the production of 
toxic metabolites. Our results failed to provide evidence that 
neutrophil plugging alters acute myocardial ischemia- 
reperfusion blood flow patterns in the severely damaged 
subendocardium or the more viable mid-myocardium, and 
further suggest that myocardial no reflow does not contrib- 
ute greatly to postischemic myocardial necrosis. 
Mechanisms of neutropbil-mediated injury. Although the 
presence of neutrophils at the site of tissue injury may prove 
to be an efficacious response for the scavenging and remod- 
eling of these tissues, the acute presence of neutrophils may 
be harmful to potentially viable tissue. The acute physiologic 
response to tissue injury is initiated by the various compo- 
nents of the complement system causing the chemotaxis of 
circulating neutrophils to the site of myocardial tissue injury 
(21-24). In this setting, neutrophils are known to generate 
and activate a variety of toxic metabolic pathways. Primarily 
complement fragment &-activated neutrophils produce al- 
teratioris in intracellular calcium concentrations, leading to 
the metabolism of arachadonic acid and the production of 
chemoattractants that elicit further neutrophil aggregation, 
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Table 6. Blood Flow Data (m/min per g) 
Central lschemic Zone 
- 
Depletion Control 
Nonischemic Zone 
Depletion Control 
Subendocardium 
Baseline 
2 h occlusion 
5 min reperfusion 
4 h reperfusion 
Midmyocardium 
Baseline 
2 h occlusion 
5 min reperfusion 
4 h reperfusion 
Subepicardium 
Baseline 
2 h occlusion 
5 min reperfusion 
4 h reperfusion 
1.40 t 0.10 
(n = 9) 
0.07 2 0.02’r 
(n = 11) 
3.08 z 0.26t 
(n = 9) 
0.68 + 0.07+ 
(n = IO) 
1.29 + 0.13 
(n = 9) 
0.17 t 0.05t 
(n = II) 
3.74 t 0.30t 
(n = 9) 
0.91 + 0.07* 
(n = 10) 
1.30 f 0.12 
(n = 9) 
0.49 r 0.09t 
(n = 11) 
3.06 t 0.39* 
(n = 9) 
1.36 t 0.16 
(n = 10) 
1.20 2 0.20 
(n = IO) 
0.04 + 0.01t 
(n = IO) 
2.94 2 0.461 
(n = 8) 
0.69 2 0.12" 
In = 10) 
1.13 + 0.15 
(n = IO) 
0. I4 + 0.03t 
(n = IO) 
3.93 2 0.63t 
(n = 8) 
1.06 ? 0.17 
(n = IO) 
1.20 2 0.18 
(n = IO) 
0.67 -+ 0.13* 
(n = IO) 
3.25 2 0.40t 
In = 8) 
1.57 -+ 0.21 
(n = 10) 
1.57 t 0.19 
(n = 9) 
1.57 t 0.17 
(n = 11) 
1.64 + 0.26 
(n = 9) 
1.95 + 0.22* 
(n = IO) 
1.50 + 0.18 
(n = 9) 
1.59 + 0.16 
(n = 11) 
1.70 ? 0.26 
(n = 9) 
2.06 ? 0.23* 
(n = 10) 
1.39 ? 0.15 
(n = 9) 
1.32 t 0.15 
(n = II) 
1.26 5 0.17 
(n = 9) 
1.73 ? 0.20 
(n = 10) 
1.15 ? 0.13 
(n = IO) 
1.60 + 0.30 
(n = 10) 
1.89 2 0.35 
(n = 8) 
1.58 r 0.09 
(n = IO) 
1.20 t 0.16 
(II = IO) 
1.70 + 0.26 
(n = IO) 
2.07 t 0.42 
(n = 8) 
1.84 + O.ll* 
(n = IO) 
1.20 + 0.14 
(n = IO) 
1.54 ? 0.19 
(n = IO) 
1.71 ir 0.30 
(n = 8) 
1.50 f 0.11 
(n = IO) 
--. _ _____~_ ----.- -~ 
*p < 0.05 vs. baseline; tp < 0.01 vs. baseline. Data are reported as mean values t SEM. 
degranulation and surface receptor expression (25). Neutro- 
phils are also known to generate oxygen-derived free radi- 
cals (0,~-., HO., HCIO. and RClHN.) during reperfusion 
through the enzymatic catalysis of oxygen by nicotinamide- 
adenine dinucleotide phosphate (NADPH) oxidase (15-17). 
These toxic pathways may in turn promote the production of 
oxygen-free radicals by means of xanthine oxidase, free iron 
and mitochondrial and catecholamine oxidation (15,26). Fur- 
ther cellular injury may be promoted by platelet-neutrophil 
interactions and lead to occlusive thrombus formation (27- 
30). 
Experimental research has yielded a body of information 
attempting to characterize the specijk role of neutrophils in 
promoting injury during acute coronary events. Two studies 
(12,31) have documented the presence of neutrophils in the 
capillaries of ischemic tissue using light microscopy. Neu- 
trophil immune serum and radioactive labeling techniques 
have been useful methods for identifying the sites of neutro- 
phi1 activity in ischemic myocardial tissue. Two recent 
studies (9,lO) noted indium-1 11 oxine-labeled neutrophil 
accumulation in the necrotic subendocardial regions after 3 h 
of ischemia. Engler et al. (9) found an inverse correlation 
Figure 5. An intergroup comparison of subendocardial blood flow 
at baseline, 2 h of occlusion, early reperfusion and 4 h of reperfu- 
sion. Note the similar levels of ischemic blood flow after 2 h of 
coronary occlusion in both groups (depletion versus control, p = 
NS). By 4 h of reperfusion, similar levels of myocardial no reflow in 
the ischemic zone are apparent in both groups compared with 
baseline values (p < 0.05). 
“1 
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5 
5 
E 2 
z 
1 
0 
-a- Lkp&llon 
- control 1 Irhemlc zone 
--f Dep&tlon 
- control 
Non-lsclwmlc zone 
1810 CARLSON ET AL. 
NEUTROPHIL DEPLETION AND MYOCARDIAL NO REFLOW 
JACC Vol. 14, No. 7 
December 1989~1803-13 
5- 
4- 
E 
P 3- 
g 
E 
2- 
l- 
04 
Bssdlm 2h 5 mln 4h 
Occktslon Rqmtfurlon Repetfuslon 
--e- oepbtton 
U Control 1 
Irchemlc zone 
-m- CapWon 
-0- Control 1 
Non-luhemlc zone 
Figure 6. An intergroup comparison of mid-myocardial blood flow 
at baseline, 2 h of occlusion, early reperfusion and 4 h of reperfu- 
sion. Note the similar levels of hyperemia after coronary reperfusion 
in both groups (p = NS). By 4 h of reperfusion, no difference in 
ischemic zone blood flow is present between the depletion and 
control groups. 
between the density of labeled neutrophils and the level of 
collateral blood flow. In a later study (14), they provided 
evidence to suggest that neutrophils accumulate throughout 
a 1 h period of ischemia, causing an increased incidence of 
arrhythmias and decreased subendocardial collateral blood 
flow. In our study, there were no differences in collateral 
flow between the depletion and control groups by 2 h of 
ischemia, suggesting that neutrophils do not obstruct collat- 
eral flow in this model of ischemia. In addition, the compa- 
rable levels of dysfunction measured using two-dimensional 
echocardiography further support our ischemic blood flow 
results and suggest that risk areas were similar between our 
groups (32). The increased presence of neutrophils during 
ischemia may simply be a marker of the severity of ischemia 
(that is, the greater the injury, the greater the neutrophil 
accumulation) and, therefore, a phenomenon that is ulti- 
mately dependent on the primary determinants of myocar- 
dial infarction: collateral blood flow, myocardial oxygen 
demand and the myocardial area at risk (33). 
The no reflow phenomenon. With reperfusion after >90 
min of ischemia, evidence of myocardial no reflow is known 
to occur. As first described by Krug et al. (34) in the cat heart 
and later by Kloner et al. (35), “no reflow” has been 
characterized as a failure to achieve uniform reperfusion in 
postischemic myocardium and is identified by severe micro- 
vascular damage of the capillaries and myocyte swelling of 
irreversibly injured myocardium. The no reflow phenome- 
non has been described clinically using thallium-201 scintig- 
raphy (36) and digital coronary arteriography (37), but its 
actual contribution to myocardial injury is unclear. 
Because there is overwhelming evidence (38) that coro- 
nary reperfusion can salvage myocardium, it can be argued 
that modification and reduction of the no reflow phenome- 
non may produce further salvage of ischemic myocardium. 
However, the importance of the no reflow phenomenon or 
its contribution to additional myocardial damage on reperfu- 
sion remains controversial. Braunwald and Kloner (38) 
described no reflow as a relatively unimportant condition of 
irreversibly injured postischemic myocardium. It develops 
in the subendocardium and is consistent with the “wave 
front” progression of necrosis toward the subepicardium, as 
described by Reimer and Jennings (39). In this sense, myo- 
cardial no reflow is a condition probably indicative of the 
most severely ischemic myocardium. The central location of 
this tissue relative to irreversibly injured myocardium and its 
anatomic isolation from viable myocardium suggest that it 
does not contribute to reperfusion injury (38). In contrast, 
the recent attention focused on the unique and potentially 
destructive properties of the neutrophil suggest that no 
reflow may be a primary result of neutrophil-mediated myo- 
cardial tissue damage (7,9,12,25). The implications of this 
argument further suggest that neutrophils may also be the 
source of other severe pathophysiologic conditions associ- 
ated with ischemia and reperfusion. Neutrophils may impose 
an additional risk during reperfusion, but it is also possible 
that the relative importance of this injury may be overesti- 
mated. Clearly, additional studies examining the pathophys- 
iologic significance of the no reflow phenomenon and its 
contributing factors or lack thereof are necessary. 
The cause of no reflow is incompletely understood; at 
leastfive potential factors have been implicated: 1) endothe- 
lial damage by ischemia or oxygen free radicals, or both, 
2) interstitial edema, 3) myocyte swelling, 4) fibrin thrombo- 
sis, and 5) white blood cell plugs. More recent evidence 
suggests a primary role of leukocyte plugging in producing 
depressed myocardial blood flow during reperfusion. An 
approximate fivefold increase in neutrophil accumulation to 
the subendocardium has been reported (9,lO) after reperfu- 
sion after 3 h of ischemia, which may contribute to postis- 
chemic no reflow and other tissue injury. This dramatic 
increase in neutrophil content has been postulated to cause 
increased vascular resistance and permeability in postische- 
mic skeletal muscle (2), an increase in postischemic myocar- 
dial edema and myocardial no reflow (9,10,12-14,35). In our 
study, no differences were found in myocardial blood flow 
patterns measured at early reperfusion and 4 h of reperfusion 
between a control group receiving nonimmune serum and an 
experimental group attaining an 81% depletion of circulating 
neutrophils with immune serum. Our results agree with the 
findings of a recently published study by de Lorgeril et al. 
(4), who used a similar neutrophil depletion mode1 of ische- 
mia and reperfusion. 
Ourfindings also support earlier reports (38,40-42), sug- 
gesting that reduced blood flow after reperfusion occurs in 
JACC Vol. 14 No. : 
December 198’9:1803-13 
CARLSON ET AL. 1811 
NEUTROPHIL DEPLETION AND MYOCARDIAL NO REFLOW 
the postischemic subendocardium and mid-myocardium. 
The present findings, however, suggest that no reflow occurs 
regardless of neutrophil depletion and that two alternative 
pathophysiologic relations may be occurring. On the one 
hand, the significantly lower subendocardial blood flow 
observed by 4 h of reperfusion and the visible evidence of 
necrosis in this region in both groups are anatomically 
consistent with myocardial no reflow. A blunted hyperemic 
response after reperfusion was also noted in the postische- 
mic subendocardium, which also may be indicative of the 
subendocardial no reflow observed at 4 h of reperfusion. The 
mid-myocardium for both groups, however, demonstrated 
differing flow characteristics compared with the subendocar- 
dium that cannot be explained by neutrophil depletion or 
myocardial no reflow. After reperfusion, the hyperemic 
response in the mid-myocardium was maximum for both 
groups, suggesting that this region was more capable of 
reperfusion than the subendocardium and, therefore, was 
not as severely damaged. It is unlikely that “classic” no 
reflow exists in the mid-myocardium given that no reflow is 
primarily a subendocardial phenomenon (34,35). An alterna- 
tive explanation for significantly lowered mid-myocardial 
flow at 4 h of reperfusion is the decreased oxygen demand 
resulting from the “stunned”condition of the postischemic 
myocardium. These results may in part be explained by a 
study by Kloner and Alker (41) who found that low subepi- 
cardial blood flow in postischemic myocardium inconsistent 
with no reflow occurs as a result of the lowered oxygen 
demand of postischemic “stunned” myocardium. Buda et 
al. (43) similarly demonstrated that a positive relation may 
exist between the level of functional recovery achieved and 
the level of myocardial blood flow after reperfusion of 
postischemic myocardium. 
Various other reports have suggested that mechanisms 
other than neutrophil plugging may potentially contribute to 
the no rejow phenomenon. For example, Olafsson et al. (44) 
reported increased lateral ischemic reflow at 1 h of reperfu- 
sion, an improvement in regional left ventricular function at 
3 and 24 h of reperfusion and evidence of decreased neutro- 
phi1 infiltration after infusion of intracoronary adenosine. 
This study fails to provide evidence of no reflow in the 
control group as it suggests, but supports the premise that 
the improved regional function and myocardial blood flow 
produced by adenosine may operate on a supply and demand 
basis (41.43). Golino et al. (45) documented increased no 
reflow in hypercholesterolemic rabbits compared with hy- 
percholesterolemic rabbits given antiplatelet serum. This 
study presents evidence that platelets contribute to no reflow 
during hypercholesterolemia, but do so in a model that adds 
an additional pathologic variable to this question. Moreover, 
an autologous platelet-labeling study (30) coupled with neu- 
trophil depletion found that platelet accumulation during 
ischemia decreases. Thus, it is unclear whether the neutro- 
phi1 antiserum produced this effect and whether platelets 
have any bearing on reducing myocardial blood flow. In 
contrast, fibrinolytic therapy using streptokinase produced 
no effect on myocardial no reflow in the dog (41), thus 
suggesting that fibrin thrombi are not an important factor in 
the no reflow phenomenon. 
Infarct size reduction by neutrophil depletion. Two hours 
of ischemia followed by 4 h of reperfusion with an 81% level 
of neutrophil depletion, although not altering myocardial 
blood flow between the groups, did produce a protective 
effect defined in terms of infarct size reduction. This result is 
consistent with the reports of others suggesting that a 
cardioprotective effect of reperfused myocardium is 
achieved after interventions that decrease the level of circu- 
lating neutrophils (l-4,6,12) or altered neutrophil expression 
(5,6). Two studies (3,10), however, have reported a failure of 
neutrophil depletion to reduce infarct size with 3 h of 
occlusion followed by 21 h of reperfusion in a conscious 
canine model and in an acute study with 4 h of occlusion and 
4 h of reperfusion. The failure to observe a reduction in 
infarct size may relate to the longer period of ischemia 
present in both of these studies. Clearly, the duration of 
ischemia is important in determining the amount of viable 
myocardium present after reperfusion (39). Jennings and 
Reimer (46) showed that little salvageable myocardial tissue 
remains in an anesthetized canine model after 3 h of ische- 
mia. Thus, it may be that longer periods of ischemia produce 
maximal ischemic damage, thereby decreasing the amount of 
viable myocardium susceptible to neutrophil-mediated in- 
jury. 
Other possible explanations may account for the ob- 
served diferences in infarct size (33). Commonly, infarct 
size is reported as both a percent of the left ventricular mass 
or area at risk. This latter measure takes into effect a 
possible difference in ischemic perfusion bed size, which is 
known to positively influence the ultimate size of myocardial 
necrosis. However, the primary goal of our study was to 
observe the effect of neutrophil depletion on myocardial flow 
patterns after reperfusion, making our infarct size results an 
important but a secondary issue in this study. Risk areas 
were not directly measured in our study and, therefore, we 
presented infarct size as a percent of left ventricular mass. 
We believe that the infarct size reduction produced by 
neutrophil depletion is accurate because of the similarity in 
ischemic blood flow and variables of dysfunction between 
the groups, which we have previously shown to correlate 
well with risk area measurement (32,47). In addition, other 
neutrophil depletion studies (1,3) have reported a reduction 
in infarct size expressed as a percent of the left ventricular 
weight. 
Effect of neutrophil reduction on myocardial function. The 
effect of neutrophil depletion on left ventricular function 
variables after prolonged coronary occlusion and reperfu- 
sion has not been well studied. In a brief ischemia- 
reperfusion model, Engler and Cove11 (7) reported a >lOO% 
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recovery of function up to 1 h of reperfusion during agran- 
ulocytopenia compared with only 76% recovery in a control 
group. This study was performed in a myocardial 
“stunning” model of 15 min of ischemia, which produces no 
infarction. More recently, however, other investigators 
(4849) using a similar model of systemic neutropenia did not 
prevent myocardial dysfunction after 15 min of ischemia in 
dogs. In this regard, after more prolonged ischemia, we 
observed that neutrophil depletion did not alter ischemic or 
postischemic myocardial wall thickening measurements 
compared with the nonimmune serum control group. Both 
groups experienced a relative return of hypokinetic function 
on reperfusion that progressed toward akinesia by 4 h, which 
is consistent with a previous study (20). 
Potential limitations of the study. A potential criticism of 
our study may be that a greater level of neutrophil depletion 
is needed to attenuate the no reflow phenomenon as sug- 
gested in a study by Engler and Cove11 (7) of stunned 
myocardium after 15 min of ischemia. Their findings suggest 
that a partial depletion of neutrophils may not prevent 
certain forms of injury because of their great capacity to 
cause such injury. If this hypothesis is correct, then it is 
possible that the 81% depletion of neutrophils in our study 
failed to prevent no reflow as we found. However, given our 
infarct size results, this would suggest that myocardial no 
reflow has little effect on reperfusion injury and the ultimate 
size of necrosis. Moreover, it is important to note that the 
study of Engler and Cove11 (7) did not produce a duration of 
ischemia sufficient to properly study myocardial no reflow. 
Furthermore, because no differences in myocardial blood 
flow after reperfusion were found in their myocardial stun- 
ning model, it is unlikely that their findings are directly 
applicable to our results in a prolonged ischemia model. It is 
possible that more effective methods of neutrophil depletion 
using Leukopak filters or Mol receptor site inactivation 
techniques may alter myocardial no reflow; however, no 
study to date using these methods has examined the no 
reflow phenomenon after prolonged ischemia. Another con- 
cern is that the strong chemotactic attraction of neutrophils 
to ischemic tissue may not be entirely prevented by the 81% 
depletion of circulating neutrophils resulting from antiserum 
techniques. However, several studies (1,3,6) using antise- 
rum depletion methods have demonstrated significantly de- 
creased levels of neutrophil infiltration in postischemic myo- 
cardium by histologic examination. These results suggest 
that neutrophil infiltration is reduced in the region of injury 
as a result of neutrophil antiserum administration. 
Clinical significance. Neutrophils appear to play an im- 
portant role in the pathophysiology of myocardial infarction. 
The clinical practicality of neutrophil manipulation during 
the onset and resolution of acute myocardial ischemia is 
unclear. The actual importance of neutrophil depletion dur- 
ing ischemia compared with reperfusion also poses another 
area of uncertainty relative to the presence of neutrophil- 
mediated injury and the efficacy of clinical intervention. 
Current efforts to mask Mol surface receptor sites on 
neutrophils (8) using antibodies to acutely inactivate neutro- 
phils or alter the response of the complement system may 
offer more clinically applicable means to reduce neutrophil- 
mediated myocardial injury. 
Conclusions. The depletion of 81% of the neutrophils in 
our canine model failed to alter myocardial blood flow 
patterns or functional recovery during 2 h of ischemia 
followed by 4 h of reperfusion. The neutrophil depletion and 
control groups experienced equal levels of subendocardial 
no reflow and left ventricular dysfunction by 4 h of reperfu- 
sion. Neutrophil depletion did, however, produce a reduc- 
tion in infarct size compared with the control group. These 
experimental results provide evidence to suggest that neu- 
trophil-mediated tissue injury is derived from the production 
of toxic metabolites rather than capillary plugging. 
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